Answers are grounded in this paper and cite their sources.
You have accessJournal of UrologyGlobal Health/Humanitarian (PD15)1 May 2024PD15-12 MANAGEMENT OF PROSTATE CANCER IS ASSOCIATED WITH SIGNIFICANT HEALTHCARE COSTS–AN ANALYSIS FROM A CARIBBEAN HOSPITAL Amanda Wibben, Geneva Pantoja, Satyendra A. Persaud, Visham Bhagaloo, and Sara Seetaram Amanda WibbenAmanda Wibben , Geneva PantojaGeneva Pantoja , Satyendra A. PersaudSatyendra A. Persaud , Visham BhagalooVisham Bhagaloo , and Sara SeetaramSara Seetaram View All Author Informationhttps://doi.org/10.1097/01.JU.0001008648.33830.32.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Trinidad is among the world's highest in incidence and mortality rates of prostate cancer in the world. Furthermore, prostate cancer places a significant burden on the Trinidadian health sector. Since little literature exists regarding the economic burden of prostate cancer, two medical students from the US were supported by the Urology Care Foundation in conducting research in Trinidad to analyze the annual costs associated with the diagnosis and treatment of prostate cancer in a large, public hospital in Trinidad. METHODS: A prospective cost of illness study was done analyzing one month of all prostate cancer-related events at the San Fernando General Hospital (SFGH). These included inpatient admissions, outpatient admissions and surgical procedures. All resources utilized during these visits were logged and itemized and an assigned cost was provided by the Costing Unit of SFGH. An annual cost was extrapolated. RESULTS: 208 outpatient visits and 8 acute presentations were recorded for the month, and an estimated 2496 outpatient visits and 96 acute admissions occurred annually. Annual elective procedures included 54 orchidectomies and 22 radical prostatectomies. 40 patients were referred externally for prostate radiotherapy (billed to the Ministry of Health). Goserelin injections were administered to an estimated 636 patients. The overall estimated cost to the Regional Health Authority was TTD14,052,157.66 (USD $2,066,493). Outpatient visits related to the screening, diagnosis, or management of prostate cancer, including prostate biopsies, attributed to the majority of the costs (53%), while nephrostomies related to lower urinary tract symptoms from prostate cancer attributed the least (0.7%). Additionally, patients' demographic information was collected. 61% of the patients who presented were of African descent, showing that prostate cancer disproportionately affects Black men in Trinidad. CONCLUSIONS: This analysis shows that prostate cancer has a significant financial burden on the Trinidadian economy. Efforts must be dedicated to screening and prevention and policymakers should be aware of the economic impact of the disease when budgetary allocations are made. It is also important to note that Black men presented with prostate cancer at higher rates in both the acute and outpatient settings, highlighting the disproportionate nature of the disease and progression. Source of Funding: Urology Care Foundation–official foundation of the American Urological Association © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e364 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Amanda Wibben More articles by this author Geneva Pantoja More articles by this author Satyendra A. Persaud More articles by this author Visham Bhagaloo More articles by this author Sara Seetaram More articles by this author Expand All Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Wibben et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: